Brought to you by:
Envveno Medical reports successful completion of first VenoValve surgery in US pivotal trial
Envveno Medical—formerly Hancock Jaffe Laboratories—recently announced that the first VenoValve surgery in the company’s SAVVE US pivotal trial for the VenoValve has been successfully completed. The surgery was performed by Adriana Laser, MD, associate professor of surgery at Albany Medical…
WIfI system helps predict revascularization benefit for diabetic patients with CLTI, study finds
A retrospective study supports the use of the Wound, ischemia, and foot infection (WIfI) classification system to predict the revascularization benefit for diabetic patients with chronic limb-threatening ischemia (CLTI). The WIfI classification system was developed to stratify the risk of major amputation at one…
Our broken system: Medical liability in vascular practice
My last editorial, “How to succeed in vascular surgery: A guide for the aspiring outlier,” was more controversial than I expected. I naively believed that a critical expose of vascular surgery’s “1%” would be welcomed by roughly 99% of vascular…
Sanford invents Breakthrough Device for TAAA
An investigational device invented at Sanford Health in Sioux Falls, South Dakota, that helps high-risk vascular disease patients has been granted a Breakthrough Device designation by the Food and Drug Administration (FDA). Patrick Kelly, MD, a Sanford Health vascular surgeon,…
Julie A. Freischlag to be installed as ACS president
Former Society for Vascular Surgery (SVS) President Julie A. Freischlag, MD, will be installed as the 2021-22 president of the American College of Surgeons (ACS) at the ACS Convocation Sunday, Oct. 24. Freischlag led the SVS from 2013–14, the first…
WVS 2021: Western Vascular Society names new president-elect
University of Southern California (USC) vascular chief Vincent Rowe, MD, took over as the new president of the Western Vascular Society (WVS)—with University of Arizona chief of vascular surgery Wei Zhou, MD, named the new president-elect—during the organization’s 2021 annual…
WVS 2021: Community surgeons report improved rAAA survival after adoption of EVAR-first approach
Overall survival improved from 71% to 80% after a group of community practice surgeons started using an endovascular-first approach to ruptured abdominal aortic aneurysm (rAAA) repair. Scott S. Berman, MD, a vascular surgeon at Pima Heart & Vascular in Tucson,…
The top 10 most popular Vascular Specialist stories in September
Five-year data from the ACST-2 trial comparing carotid endarterectomy and carotid artery stenting, a report from the Crawford Forum at the 2021 Vascular Annual Meeting (VAM), and an Eastern Vascular Society (EVS) annual meeting piece reporting on vascular surgery as…
Three-year VIVO results back ‘continued safety and effectiveness’ of Zilver Vena venous stent
Three-year results of the VIVO clinical study support the continued safety and effectiveness of the Zilver Vena venous stent (Cook Medical) in the treatment of symptomatic iliofemoral venous outflow obstruction, attendees at the Vascular Interventional Advances (VIVA) 2021 (Oct. 5–7) in Las Vegas.…
SVS task force continues fight to stop cuts
The Society for Vascular Surgery (SVS) Medicare Cuts Task Force is continuing its work to stop the proposed cuts in physician reimbursement from going through as planned in 2022. The task force was created to respond to the proposed 2022…